Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ONDANSETRON

ONDANSETRON

Standard Dose
4MG/2ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ONDANSETRON is listed in Drugs@FDA under application 079032 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ONDANSETRON Form and strength INJECTABLE; INJECTION - 4MG/2ML Sponsor AM REGENT Submission history Latest submission status date: 2015-01-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ONDANSETRON is listed in Drugs@FDA under application 079032 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ONDANSETRON Form and strength INJECTABLE; INJECTION - 4MG/2ML Sponsor AM REGENT Submission history Latest submission status date: 2015-01-15 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.